Visa signed a definitive agreement to acquire BioCatch from funds advised by Permira and other shareholders for $2.4 billion in cash.
Visa to acquire BioCatch ↗ · repeat of an earlier article
What happened
- BioCatch reports protecting 1.8 billion devices and 760 million users and serving more than 350 banking clients in 21 countries.
- The transaction is subject to customary closing conditions, including receipt of applicable regulatory approvals, and is expected to close by the end of Visa's fiscal second quarter of 2027.
Why it matters to Signicat
- A payments network acquiring a behavioral fraud vendor is a direct move into bank digital-session fraud prevention, an adjacent space to Signicat's document IDV and risk screening lines.
- The deal is a change of ownership of a fraud-intelligence competitor to a large payments player, which may shift bank buying criteria toward bundled payments-plus-fraud offerings.
Evidence from the source (4 quotes)
- “BioCatch protects 1.8 billion devices and 760 million users around the world, serving more than 350 banking clients in 21 different countries, including more than 100 of the largest banks globally.” source ↗
- “The transaction is subject to customary closing conditions, including receipt of applicable regulatory approvals. The transaction is expected to close by the end of Visa’s fiscal second quarter of 2027” source ↗
- “The acquisition of BioCatch complements Visa’s existing cyber, fraud, risk, and security solutions” source ↗
- “from funds advised by Permira and other shareholders for $2.4 billion in cash” source ↗
Fraud deepfake injectionOrchestration platformM&AGlobal
3 of 3 facts verified against the source · confidence high · claude-haiku-5-5